
Biofrontera posts strong 17% revenue growth but wider Q1 loss than expected
Biofrontera Inc. reported a mixed Q1 2026 with a 17% revenue increase to $10.08 million, showing strong sales growth despite missing analyst revenue expectations slightly. The company posted a loss of $0.41 per share, wider than the estimated $0.12 l...

